Celanese Triggers Major Moves in Q1 2025 with 3B Spin-Off and Price Hikes Amid 0.15 Loss
Celanese Corporation is shaking up its strategy with several bold decisions announced in early May. The company plans to divest its Micromax® electronic materials business, projecting over $300 million in revenue by 2025 from this unit alone. The move, endorsed by the board, is aimed at boosting cash flow and lowering debt, aligning with the company’s long-term strategy.
Alongside the spin-off news, Celanese will raise prices across its engineering materials lines, effective June 1, 2025. This decision reflects pressure from increasing logistics costs, regulatory shifts, and raw material inflation. This marks the second price hike in 2025, with broader product coverage than the February announcement.
In terms of financials, Q1 2025 was a mixed bag. Net sales reached $2.4 billion, a 1% sequential increase, driven by 2% volume growth, partially offset by currency fluctuations. However, year-over-year sales dropped 8%, and adjusted EBIT plunged 42%. Despite this, adjusted EPS came in at $0.57, topping analyst expectations of $0.39 and exceeding the company’s own forecast.
Micromax® is a global leader in advanced electronic inks and pastes, used in sectors ranging from military to medical devices. Its strengths lie in durability, flexibility, and multi-industry compatibility, addressing rising demand from miniaturization, EV growth, and wearables. By offloading Micromax®, Celanese aims to focus more resources on core high-growth assets.
The company’s move echoes DuPont’s decision to spin off its electronics business, now named Qnity, which will become a publicly traded firm by November 1, 2025. Unlike Celanese, DuPont’s electronics division has been a profit engine, with nearly 48% of total sales in 2024. Booming demand for AI-related semiconductors and next-gen interconnects has driven double-digit sales and EBITDA growth for DuPont.
Celanese continues to struggle with margin compression. In Q1 2025, its acetyl chain business saw EBIT drop over 43%, while engineering materials EBIT fell 37%. Regionally, Asia demand remained soft, and Western Hemisphere automotive destocking persisted. Still, Celanese’s engineering business saw a 5% sequential volume increase in auto-related sales, and continued to optimize its product mix toward higher-margin offerings.
With plans to cut $120 million in annual costs, up from the previously announced $80 million, the company is eyeing efficiencies in logistics, SG&A, and production. Celanese expects Q2 adjusted EPS to land between $1.30 and $1.50, down from $2.38 a year ago, but stronger than Q1. The firm remains confident in its resilience amid trade policy shifts, citing minimal Q1 impact from tariffs and steady demand.
Investors will be watching closely as Celanese executes its cash-first, leaner-growth strategy, hoping to regain its status as a top-tier shareholder return company.
2026-07-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Laboratoire PYC showcases its collagen-driven nutricosmetic innovations
-
Kemira to Acquire SIDRA Wasserchemie, Expanding European Water Treatment Footprint
-
The Last 10% Tariff Trap: A New Chapter in U.S.–China Negotiations on “Fentanyl Tariffs”
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
Axplora Expands Indian Market: €6.5 Million to Expand API Manufacturing in Vizag
-
DKSH Upgrades its Malaysia Innovation Center to Strengthen Technical Service Capabilities for the Southeast Asian Market
-
Lilly Bets Bigger on China
-
Rising API Costs Threaten Drug Prices
-
New Titanium Dioxide Alternative Moves Closer to Market
-
China Suspends Sulfuric Acid Exports, Global Copper and Fertilizer Supply Under Strain
Recommend Reading
-
South Africa Wants Lenacapavir at Home, Not Just Imported
-
Affordable GLP-1s Could Rewrite the Global Obesity Market
-
Afidopyropen: The Silent Assassin of Sap-Sucking Pests—Promise, Pitfalls, and the Path to Sustainable Deployment
-
Jiangsu Fengshan Biochem Gears Up for Strategic Expansion in Selective Herbicide Intermediates and Active Ingredients
-
Agrochemical Markets at a Crossroads: Winter Stockpiling Begins Amid Cost Pressures and Fragmented Demand
-
Nature’s Blueprint, Science’s Edge: Corteva Unveils Twin Breakthroughs to Tackle the $70 Billion Insect Threat
-
Pesticide Market in Limbo: Prices Plunge Amid Weak Demand and Overcapacity—Only a Few Hold Firm
-
Demand Slightly Increases, Butyl Alcohol Prices Rise Narrowly
-
Market Calm, Acrylonitrile Market Fluctuates within a Range in China
-
Crude oil prices fall, China's retail fuel prices are lowered again